Neurocrine Biosciences NBIX reported its Q3 earnings results on Monday, November 1, 2021 at 04:01 PM.
Here's what investors need to know about the announcement.
Earnings
Neurocrine Biosciences reported in-line EPS of $0.64 versus an estimate of $0.6, which did not surprise analysts.
Revenue was up $37,500,000 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.14, which was followed by a 4.61% drop in the share price the next day.
Here's a look at Neurocrine Biosciences's past performance:
Quarter | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
---|---|---|---|---|
EPS Estimate | 0.49 | 0.51 | 0.54 | 0.22 |
EPS Actual | 0.63 | 0.49 | 0.91 | 0.97 |
Revenue Estimate | 274.38M | 250.63M | 262.40M | 283.04M |
Revenue Actual | 288.90M | 236.60M | 247.90M | 258.50M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.